News Archives - Page 177 of 1183 - BioHealth Innovation

News

December 6, 2021

Novavax tailoring Covid-19 vaccine to Omicron variant while advancing campus expansion plans – Washington Business Journal

The company said Thursday it’s implementing “a two-pronged variant strategy” for the variant.

admin

Love0

News

December 6, 2021

Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social – The MoCo Show

Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social We…

admin

Love0

News

December 6, 2021

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022 | BioSpace

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a…

admin

Love0

News

December 6, 2021

PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease

In an interview with PharmaShots, Dr. Murat Kalayoglu, MD, Ph.D., President, and Chief Executive Officer at Cartesian Therapeutics shared his insights…

admin

Love0

News

December 6, 2021

Baltimore Startup Rasio Therapeutics Raises $1.5M for Software to Develop Drugs

A Baltimore startup that uses computer software to develop cancer drugs has raised $1.5 million in new funding, according to…

admin

Love0

Cursor and Roundcube Webmail intralytix square jpg

News

December 1, 2021

AB Agri has Partnered with Maryland’s Intralytix, Inc. to Explore the Use of Bacteriophages

Peterborough, 30 November 2021 Gut health could be boosted without reliance on antibiotics and other medicines Bacteriophages are natural and…

admin

Love0

News

December 1, 2021

Maryland’s Novavax working on its version of COVID-19 vaccine to target omicron variant

GAITHERSBURG, Md. (7News) — The Omicron variant is quickly becoming a household name but the hope is that it won’t enter households here…

admin

Love0

Business couple with computer 2021 09 02 10 31 09 utc

News

December 1, 2021

Healthtech companies reap benefits of robust year in venture capital funding | Healthcare Finance News

Venture capital investment in global healthtech companies is projected to reach $42 billion by the end of the year, according…

admin

Love0

Scientists at work 2021 09 24 03 38 22 utc

News

November 29, 2021

Bank of antibodies against nasty viruses that’s proposed for Maryland aims to prevent next pandemic.

As the world continues to grapple with the coronavirus pandemic that has claimed more than 5 million lives, a group…

admin

Love0

News

November 29, 2021

BioHealth Capital Region Spotlight: Creative Bio-Peptides Awarded $5.78 Million from NIH to Develop Breakthrough Treatments for Neuroinflammatory/Neurodegenerative Indications

Creative Bio-Peptides, Inc., an emerging drug development company focused on the development of leading-edge multi-chemokine antagonist therapeutic peptides for neuroinflammatory/neurodegenerative…

admin

Love0

News

Novavax tailoring Covid-19 vaccine to Omicron variant while advancing campus expansion plans – Washington Business Journal

Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social – The MoCo Show

United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022 | BioSpace

PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease

Baltimore Startup Rasio Therapeutics Raises $1.5M for Software to Develop Drugs

AB Agri has Partnered with Maryland’s Intralytix, Inc. to Explore the Use of Bacteriophages

Maryland’s Novavax working on its version of COVID-19 vaccine to target omicron variant

Healthtech companies reap benefits of robust year in venture capital funding | Healthcare Finance News

Bank of antibodies against nasty viruses that’s proposed for Maryland aims to prevent next pandemic.

BioHealth Capital Region Spotlight: Creative Bio-Peptides Awarded $5.78 Million from NIH to Develop Breakthrough Treatments for Neuroinflammatory/Neurodegenerative Indications

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search